The men with a positive PET/CT scan had significantly shorter time to BCR (Fig. 2a), to skeletal metastasis (Fig. 2b), and to prostate cancer-specific death (Fig. 2c), compared to the men with a negative PET/CT scan (all log rank p < 0.02). The gene discussed is BCR; the disease is prostate cancer.